These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16651318)

  • 1. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial.
    Petrou S; Bischof M; Bennett C; Elbourne D; Field D; McNally H
    Pediatrics; 2006 May; 117(5):1640-9. PubMed ID: 16651318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial.
    Petrou S; Edwards L;
    Arch Dis Child Fetal Neonatal Ed; 2004 May; 89(3):F263-8. PubMed ID: 15102733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR).
    Peek GJ; Elbourne D; Mugford M; Tiruvoipati R; Wilson A; Allen E; Clemens F; Firmin R; Hardy P; Hibbert C; Jones N; Killer H; Thalanany M; Truesdale A
    Health Technol Assess; 2010 Jul; 14(35):1-46. PubMed ID: 20642916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. The Extracorporeal Membrane Oxygenation Economics Working Group.
    Roberts TE
    BMJ; 1998 Oct; 317(7163):911-5; discussion 915-6. PubMed ID: 9756807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a preventive counseling and support package for postnatal depression.
    Petrou S; Cooper P; Murray L; Davidson LL
    Int J Technol Assess Health Care; 2006; 22(4):443-53. PubMed ID: 16984677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour.
    Eddama O; Petrou S; Schroeder L; Bollapragada SS; Mackenzie F; Norrie J; Reid M; Norman JE
    BJOG; 2009 Aug; 116(9):1196-203. PubMed ID: 19485990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States.
    Angus DC; Clermont G; Watson RS; Linde-Zwirble WT; Clark RH; Roberts MS
    Pediatrics; 2003 Dec; 112(6 Pt 1):1351-60. PubMed ID: 14654609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis.
    Eddama O; Petrou S; Regier D; Norrie J; MacLennan G; Mackenzie F; Norman JE
    Int J Technol Assess Health Care; 2010 Apr; 26(2):141-8. PubMed ID: 20392316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study.
    Knapp M; Windmeijer F; Brown J; Kontodimas S; Tzivelekis S; Haro JM; Ratcliffe M; Hong J; Novick D;
    Pharmacoeconomics; 2008; 26(4):341-58. PubMed ID: 18370568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age.
    Pediatrics; 1998 Apr; 101(4):E1. PubMed ID: 9521968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR).
    Thalanany MM; Mugford M; Hibbert C; Cooper NJ; Truesdale A; Robinson S; Tiruvoipati R; Elbourne DR; Peek GJ; Clemens F; Hardy P; Wilson A;
    BMC Health Serv Res; 2008 Apr; 8():94. PubMed ID: 18447931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group.
    Lancet; 1996 Jul; 348(9020):75-82. PubMed ID: 8676720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of neonatal ECMO using existing evidence.
    Howard S; Mugford M; Normand C; Elbourne D; Grant A; Field D; Johnson A
    Int J Technol Assess Health Care; 1996; 12(1):80-92. PubMed ID: 8690565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.
    Mugford M; Elbourne D; Field D
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001340. PubMed ID: 18646070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.
    Peek GJ; Mugford M; Tiruvoipati R; Wilson A; Allen E; Thalanany MM; Hibbert CL; Truesdale A; Clemens F; Cooper N; Firmin RK; Elbourne D;
    Lancet; 2009 Oct; 374(9698):1351-63. PubMed ID: 19762075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.
    Elbourne D; Field D; Mugford M
    Cochrane Database Syst Rev; 2002; (1):CD001340. PubMed ID: 11869599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.
    Sculpher MJ; Poole L; Cleland J; Drummond M; Armstrong PW; Horowitz JD; Massie BM; Poole-Wilson PA; Ryden L
    Eur J Heart Fail; 2000 Dec; 2(4):447-54. PubMed ID: 11113723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopy for Helicobacter pylori sero-negative young dyspeptic patients: an economic evaluation based on a randomized trial.
    Asante M; Lord J; Mendall M; Northfield T
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):851-6. PubMed ID: 10514116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.